TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|---|---|---|---|---|---|---|---|---|---|---|
| S | %ret | 1 | 1 | 2 | -6 | 6 | 4 | -14 | -39 | -5 | -9 |
| S | %wins | 100 | 0 | 0 | 50 | 100 | 100 | 58 |
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
11/19/15 16:06 | 11/17/15 | PRTA | Prothena Corp Plc | L2 | Health | Drug | Pharmaceutical Preparations | Schenk Dale B. | CA | DO | P,CEO | S.d | -2,021 | 67.37 | 18 | -30 | -67 | 15 | M | 166 | 199 | 106 | 24 | 59 | 32 | 13 | 4 | 0 | 4 | 1 | -52 | -41 | -8 |
8/21/15 16:05 | 8/20/15 | PRTA | Prothena Corp Plc | L2 | Health | Drug | Pharmaceutical Preparations | Schenk Dale B. | CA | DO | P,CEO | S.d | -1,700 | 56.65 | 27 | -30 | -72 | 12 | D | 222 | 163 | 108 | 66 | 7 | -16 | -13 | -11 | -12 | 7 | 6 | 24 | -37 | -1 |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |